Rhumbline Advisers Sells 7,910 Shares of Globe Life Inc. $GL

Rhumbline Advisers lowered its position in shares of Globe Life Inc. (NYSE:GL) by 3.7% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 204,400 shares of the company’s stock after selling 7,910 shares during the quarter. Rhumbline Advisers owned 0.25% of Globe Life worth $29,223,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Invesco Ltd. boosted its position in Globe Life by 3.9% during the second quarter. Invesco Ltd. now owns 3,921,439 shares of the company’s stock valued at $487,396,000 after purchasing an additional 147,644 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Globe Life by 2.9% in the 2nd quarter. Geode Capital Management LLC now owns 2,722,768 shares of the company’s stock valued at $339,875,000 after purchasing an additional 76,995 shares during the period. AQR Capital Management LLC raised its holdings in shares of Globe Life by 98.6% in the 2nd quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock valued at $174,340,000 after purchasing an additional 696,548 shares during the period. Norges Bank acquired a new stake in Globe Life in the 2nd quarter valued at about $157,722,000. Finally, Bank of New York Mellon Corp grew its holdings in Globe Life by 3.6% during the second quarter. Bank of New York Mellon Corp now owns 1,248,025 shares of the company’s stock worth $155,117,000 after purchasing an additional 43,095 shares during the period. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Globe Life Trading Up 0.2%

Shares of Globe Life stock opened at $144.46 on Monday. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41. Globe Life Inc. has a 12-month low of $109.38 and a 12-month high of $152.71. The company has a market capitalization of $11.50 billion, a price-to-earnings ratio of 10.26 and a beta of 0.47. The firm’s 50-day moving average price is $140.57 and its two-hundred day moving average price is $138.39.

Globe Life (NYSE:GL) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.44 by ($0.05). The company had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.53 billion. Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period last year, the firm posted $3.14 earnings per share. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, analysts forecast that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Insider Transactions at Globe Life

In related news, CEO Frank M. Svoboda sold 9,379 shares of the firm’s stock in a transaction that occurred on Tuesday, December 16th. The shares were sold at an average price of $140.43, for a total value of $1,317,092.97. Following the completion of the transaction, the chief executive officer owned 35,868 shares in the company, valued at $5,036,943.24. This trade represents a 20.73% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Mark A. Blinn sold 1,750 shares of the business’s stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $147.91, for a total transaction of $258,842.50. Following the sale, the director directly owned 3,372 shares in the company, valued at $498,752.52. The trade was a 34.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 51,129 shares of company stock worth $7,414,035. Insiders own 1.97% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on GL. Morgan Stanley restated an “overweight” rating and issued a $176.00 price objective on shares of Globe Life in a research note on Monday, December 15th. Piper Sandler reissued an “overweight” rating and set a $167.00 target price on shares of Globe Life in a report on Friday, November 21st. Truist Financial raised their price target on Globe Life from $158.00 to $180.00 and gave the company a “buy” rating in a report on Friday, February 6th. Keefe, Bruyette & Woods lifted their price objective on shares of Globe Life from $160.00 to $162.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 28th. Finally, Evercore lowered shares of Globe Life from an “outperform” rating to an “in-line” rating and set a $155.00 price objective on the stock. in a research report on Tuesday, January 6th. Eight equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $171.00.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.